Mark Harries
Impact in
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 40
- Cutaneous Melanoma Detection and Management 17
- Cancer Treatment and Pharmacology 8
- CAR-T cell therapy research 7
- HER2/EGFR in Cancer Research 6
-
- Melanoma and MAPK Pathways 9
- Co-authors
- Martin Gore (10 shared papers)Ian Smith (1 shared paper)Mary Collins (3 shared papers)Arnie Purushotham (7 shared papers)Stanley B. Kaye (1 shared paper)James Spicer (5 shared papers)K. Acland (8 shared papers)Lars Holmberg (4 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (4 papers)The Lancet Oncology (3 papers)European Journal of Cancer (3 papers)International Journal of Clinical Practice (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Harries
60 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 103
- Oncology 909
- Reproductive Medicine 153
- Cancer Research 244
- Immunology 318
- Radiology, Nuclear Medicine and Imaging 266
Countries citing papers authored by Mark Harries
This map shows the geographic impact of Mark Harries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harries more than expected).
Fields of papers citing papers by Mark Harries
This network shows the impact of papers produced by Mark Harries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harries. The network helps show where Mark Harries may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Harries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 151 | |
| 2 | 2002 | 131 | |
| 3 | 2002 | 118 | |
| 4 | 2014 | 116 | |
| 5 | 2001 | 90 | |
| 6 | 2011 | 88 | |
| 7 | 2014 | 75 | |
| 8 | 2014 | 73 | |
| 9 | 1999 | 72 | |
| 10 | 2014 | 65 | |
| 11 | 2014 | 65 | |
| 12 | 2011 | 65 | |
| 13 | 2023 | 56 | |
| 14 | 2004 | 52 | |
| 15 | 2021 | 51 | |
| 16 | 2015 | 51 | |
| 17 | 2015 | 50 | |
| 18 | 2003 | 49 | |
| 19 | 2001 | 46 | |
| 20 | 2016 | 43 |
About Mark Harries
Mark Harries is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (17 papers), Melanoma and MAPK Pathways (9 papers), Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (7 papers), CAR-T cell therapy research (7 papers), HER2/EGFR in Cancer Research (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (909 citations), Reproductive Medicine (153 citations), Cancer Research (244 citations), Immunology (318 citations) and Radiology, Nuclear Medicine and Imaging (266 citations). Mark Harries has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Martin Gore, Ian Smith, Mary Collins, Arnie Purushotham, Stanley B. Kaye, James Spicer, K. Acland, Lars Holmberg, Hans Garmo and Janine Mansi. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, The Lancet Oncology, European Journal of Cancer and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.